专栏名称: 毕凯今选
由毕凯医药为您每周跟踪PUBMED十大瘤种最新前沿进展,编译制作,每日分享推送,希望我们的一点点绵薄之力,能为临床助力,做医生的朋友,做患者的帮助!
今天看啥  ›  专栏  ›  毕凯今选

【其他高分选 083】

毕凯今选  · 公众号  ·  · 2024-12-31 15:19
    

文章预览

BC PMID:39711226 IF:27.4 Personalized Multi-Epitope Nanovaccine Unlocks B Cell-Mediated Multiple Pathways of Antitumor Immunity SCI:Adv Mater PMID:39715100 IF:12.5 Label-free discrimination analysis of breast cancer tumor and adjacent tissues of patients after neoadjuvant treatment using Raman spectroscopy: a diagnostic study SCI:Int J Surg PMID:39721034 IF:14.3 Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine-Mediated Radiosensitization for Triple-Negative Breast Cancer Therapy SCI:Adv Sci (Weinh) PMID:39719646 IF:10.6 Natural epigallocatechin-3-gallocarboxylate nanoformulation loaded doxorubicin to construct a novel and low cardiotoxicity chemotherapeutic drug for high-efficiency breast cancer therapy SCI:J Nanobiotechnology PMID:39724577 IF:12.5 Elastography-based AI model can predict axillary status after neoadjuvant chemotherapy in breast cancer with nodal involvement: A prospective, multicenter, diagnostic study SCI:Int J Surg PMID:39723610 IF ………………………………

原文地址:访问原文地址
快照地址: 访问文章快照
总结与预览地址:访问总结与预览